 CAMBRIDGE, Mass., April 05, 2021 GLOBE NEWSWIRE -- Evelo Biosciences Nasdaq:EVLO, a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that management will present a company overview at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12th 2:15 p.m. ET. 